Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways-Reference-Cited by-同舟云学术

Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways

Author:

Xiao Xi¹,Chen Mengke²,Sang Ye²,Xue Junyu¹,Jiang Ke³,Chen Yulu²,Zhang Luyao¹,Yu Shuang¹,Lv Weiming⁴,Li Yanbing¹,Liu Rengyun²^ORCID,Xiao Haipeng¹

Affiliation:

1. Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

2. Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

3. Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

4. Department of Breast and Thyroid Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference50 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献